Save time and get answers to complex questions with AI chat
Patent tenofovir alafenamide gilead?Patent term adjustment semaglutida?Bivalirudin manufacturer?Is guselkumab off patent in u s?Allergan's patent for latisse expired?
See the DrugPatentWatch profile for ingrezza
FDA Approval Date for Ingrezza (valbenazine): September 10, 2019 Valbenazine received FDA approval on that date under a New Drug Application (NDA) for the treatment of tardive dyskinesia in adults.
Other Questions About Ingrezza :